Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Exposure to anaesthetic agents does not affect multiple sclerosis risk.
Editorial comment.
A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms?
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
One step forward in the quest for evidence of the efficacy of cognitive rehabilitation in multiple sclerosis.
[Treatment of relapses of multiple sclerosis (a review)].
[Kidney function tests in multiple sclerosis].
2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro.
A mechanism-based classification of pain in multiple sclerosis.
Epstein-Barr virus infection: A smoking gun for multiple sclerosis?
Microsatellite polymorphism in haem oxygenase 1 gene promoter in multiple sclerosis.
Brain stem and cerebellar atrophy in chronic progressive neuro-Behçet's disease.
Glial progenitor cell-based treatment and modeling of neurological disease.
Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.
Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.
Disability progression in relapsing MS is more than just lesions: The lesson of fingolimod.
Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development.
Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals.
Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes.
Early netrin-1 expression impairs central nervous system remyelination.
Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies.
Fibrinogen: A Circulating Factor in Search for Its Genetic Architecture.
FDA warns about the risks of unproven surgical therapy for multiple sclerosis.
The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS.
Pages
« first
‹ previous
…
338
339
340
341
342
343
344
345
346
…
next ›
last »